芍麻止痉颗粒 | China Drugs ListShaoma Zhijing granules | China Drugs List
本页为公开参考信息，不构成医疗建议、处方或药品供应要约。请向持证专业人士确认当前批准情况、可获得性及适用性。
- 药品类型
- 中成药Traditional Chinese medicine
- 治疗领域
- 神经科Neurology
- 公开来源记录的适应症
- 平抑肝阳,息风止痉,清火豁痰。用于Tourette 综合征(抽动-秽语综合征)及慢性抽动障碍中医辨证属肝亢风动、痰火内扰者,症见头面部、颈、肩、躯干及四肢肌肉不自主的抽动或伴有口鼻、咽喉部的异常发声,急躁易怒、手足心热、睡卧不宁、大便偏干、小便短黄、舌红苔薄黄或薄黄腻。In TCM, subdues liver yang, extinguishes wind and relieves spasms, and clears fire and phlegm. For Tourette syndrome and chronic tic disorders with the TCM pattern of liver hyperactivity stirring wind and internal disturbance by phlegm-fire. Manifestations include involuntary muscle twitches of the head and face, neck, shoulders, trunk or limbs, with or without abnormal sounds from the mouth, nose or throat; irritability, hot palms and soles, restless sleep, dry stools, scant dark-yellow urine, and a red tongue with a thin yellow or thin greasy-yellow coating.
- 适应症来源与口径
- 来源日期： 2024, 2026. 适应症转录自国家医保局公开的企业申报资料；不代表已核实完整的现行说明书。Source date(s): 2024, 2026. Indications transcribed from the public NHSA manufacturer submission; this is not verification of the complete current label.
- 说明书信息局限
- 已取得完整官方药品说明书。 中国大陆说明书。Complete official prescribing information obtained. Mainland China label.
- 中国可获得性状态
- 已核实中国历史批准记录；尚未逐项核查每个产品目前是否持续上市销售。Historical Chinese approval verified; current continuous market availability has not been checked for every product.
- 海外状态
- 待逐一核查各市场。Market-by-market verification pending.
- 医保分类
- 已纳入国家医保（乙类）Included in national insurance (Category B)
- 医保版本
- 2025版；2026年1月1日起执行2025 edition; effective 1 January 2026
- 医保限制
- 该目录条目未另列限定；仍须遵守目录凡例及法定适应症No additional restriction is specified for this NRDL entry; the general NRDL rules and legally approved indications still apply.
- 医保核查说明
- 按成分／剂型名称精确或标准化匹配。报销仍取决于剂型及目录所列支付限制。Matched by exact or normalized ingredient/formulation name. Reimbursement still depends on the dosage form and listed payment restrictions.